AIA
NVO

Alera Investment Advisors’s Novo Nordisk NVO Stock Holding History

Alera Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.23M Sell
10,310
-770
-7% -$103K 0.14% 68
2024
Q2 		$1.58M Sell
11,080
-5,739
-34% -$760K 0.19% 59
2024
Q1 		$2.16M Sell
16,819
-263
-2% -$31.3K 0.29% 29
2023
Q4 		$1.77M Sell
17,082
-390
-2% -$38.6K 0.23% 32
2023
Q3 		$1.59M Sell
17,472
-76
-0.4% -$6.7K 0.26% 27
2023
Q2 		$1.42M Buy
17,548
+1,318
+8% +$108K 0.31% 34
2023
Q1 		$1.29M Buy
16,230
+316
+2% +$22.4K 0.3% 32
2022
Q4 		$1.08M Sell
15,914
-356
-2% -$20.9K 0.25% 42
2022
Q3 		$810K Sell
16,270
-20
-0.1% -$1.07K 0.23% 56
2022
Q2 		$908K Buy
16,290
+12,234
+302% +$679K 0.25% 52
2022
Q1 		$225K Buy
+4,056
New +$208K 0.05% 169
2019
Q2 		– Sell
-2,132
Closed -$56K – 694
2019
Q1 		$56K Buy
2,132
+282
+15% +$6.93K 0.03% 154
2018
Q4 		$43K Buy
+1,850
New +$41.1K 0.03% 188

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alera Investment Advisors's NVO Position: Q3 2024 in Review

Alera Investment Advisors reduced its Novo Nordisk (NVO) stake by 6.9% in Q3 2024, selling an estimated $103K and leaving 10,310 shares worth $1.23M. The position accounts for 0.14% of the portfolio, ranked #68.

Alera Investment Advisors first reported a position in NVO in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.16M in Q1 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Alera Investment Advisors held 10,310 shares of Novo Nordisk worth $1.23M as of Q3 2024.
  • Alera Investment Advisors sold 770 Novo Nordisk shares in Q3 2024, an estimated $103K.
  • Novo Nordisk made up 0.14% of Alera Investment Advisors's portfolio in Q3 2024, its #68 holding.
  • Alera Investment Advisors first reported a position in Novo Nordisk in Q4 2018 and has held it in 13 quarters since.
  • Alera Investment Advisors's Novo Nordisk position peaked at $2.16M in Q1 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.